In our previous work, we used oral cancer, pancreatic cancer, lung cancer, and glioblastoma to demonstrate that supernatant of NK cells mediates differentiation in tumors, and we have validated this based on IFN-γ and TNF-α levels [19, 40, 59]. The gene discussed is IFNG; the disease is glioblastoma.